Cachexia (Wasting Syndrome) and cannabis in California
The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.
- ✓ Yes
- LEGAL
- 8 oz dried + 6 mature p…
- POSSESSION
- $100/yr
- STATE FEE
- 1–35 d
- TIMELINE
California statute and program
The Medical Marijuana Program (MMP) is the operating authority for California patient certification. The authoritative legal text is: California Health and Safety Code Division 10: Uniform Controlled Substances Act (cannabis provisions). The program portal is at Medical Marijuana Program (MMP).
What the evidence says about cannabis and Cachexia (Wasting Syndrome)
Cachexia is a complex metabolic syndrome characterized by severe involuntary weight loss, muscle wasting, anorexia (loss of appetite), and weakness in the setting of chronic illness. Most commonly cancer, HIV/AIDS, end-stage organ failure, and severe chronic obstructive pulmonary disease. It is distinct from simple starvation: nutritional support alone often fails to reverse the underlying metabolic dysregulation.
For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Cachexia (Wasting Syndrome) page.
How to qualify in California
The Medical Marijuana Program (MMP) requires the following registration steps for a Cachexia (Wasting Syndrome) patient (or any qualifying diagnosis):
- Get a written recommendation from a California-licensed physician. Under the Compassionate Use Act (Cal. Health & Safety Code §11362.5), any California-licensed physician (MD or DO) in good standing may issue a written recommendation for medical cannabis. California uses the broadest practitioner-discretion standard of any state — any condition for which the physician determines marijuana provides relief is eligible. The physician’s written recommendation alone is sufficient legal documentation; no state ID card is mandatory.
- (Optional) Apply for a county Medical Marijuana ID Card through the MMICP. For patients who want a state-issued ID card (recommended for travel, workplace protections, and reduced taxation at dispensaries), California maintains the voluntary Medical Marijuana Identification Card Program (MMICP) administered through county health departments. The patient applies in person at their county health department with the physician recommendation, a California driver license or state ID, and proof of residency.
- Pay the county MMICP fee (typically $50–$100, plus Medi-Cal discount). County MMICP fees vary by county but typically run $50 to $100 annually for self-pay patients (e.g., Los Angeles County is $100, San Francisco $103, San Diego $77). The MMICP includes an automatic 50% fee reduction for Medi-Cal beneficiaries under SB 420. The card is valid for one year and renewable. The physician recommendation alone (no MMICP) costs only the physician’s fee, but does not exempt the patient from cannabis excise tax at retail.
- Purchase from a California dispensary (medical or adult-use). Patients with either a current physician recommendation or an MMICP card may purchase from any of California’s 1,200+ licensed cannabis retailers. Medical patients with an MMICP card are exempt from the state’s 7.25% sales tax on medical cannabis (under SB 34) and may purchase up to 8 ounces dried plus 6 mature plants under the Compassionate Use Act — substantially higher than the 1-ounce adult-use limit. California does not honor out-of-state medical cards; visitors aged 21+ can purchase from adult-use retailers with a government ID.
- State registration fee
- $100
- Physician visit (typical)
- $50–$200
- Certification to card
- 1–35 days
- Out-of-state patients
- Not eligible
- Minors
- Eligible with caregiver
For full California registration steps, fees, and reciprocity rules, see the California cannabis-laws page.
ICD-10 code
A certifying physician documenting Cachexia (Wasting Syndrome) for the California medical cannabis program will typically record ICD-10 R64 or SNOMED-CT 238108007 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.
Frequently asked questions
Does California list Cachexia (Wasting Syndrome) as a qualifying condition for medical cannabis?
Yes. California explicitly lists Cachexia (Wasting Syndrome) as a qualifying condition under Medical Marijuana Program (MMP). A patient with a documented Cachexia (Wasting Syndrome) diagnosis can pursue state-program certification with a physician registered in the state. The qualifying-condition list is published by the state at https://www.cdph.ca.gov/Programs/CHSI/Pages/MMICP.aspx and may change as regulators add, remove, or refine entries. Inclusion on the list does not guarantee certification — a physician still has to evaluate the patient and decide that medical cannabis is appropriate for that specific case under California rules.
How do I get a California medical marijuana card for Cachexia (Wasting Syndrome)?
Step one is finding a physician licensed in California who is registered with Medical Marijuana Program (MMP) and willing to evaluate Cachexia (Wasting Syndrome) cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. California does not honor out-of-state cards, so the certification process has to originate inside the state. The state minimum patient age is 18; minors generally require a parent or legal guardian to act as caregiver. The authoritative source for the current process is the Medical Marijuana Program (MMP) site at https://www.cdph.ca.gov/Programs/CHSI/Pages/MMICP.aspx; the state updates fees, forms, and physician registration rules periodically.
What does the evidence say about cannabis for Cachexia (Wasting Syndrome)?
For Cachexia (Wasting Syndrome), evidence is described as moderate (supportive controlled studies exist but the picture is mixed). The mmjnow condition page for Cachexia (Wasting Syndrome) lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Cachexia (Wasting Syndrome) should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Cachexia (Wasting Syndrome) and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Cachexia (Wasting Syndrome); the evidence position above describes whether trial data supports its use, not whether it should replace standard care.
Sources
- California Health and Safety Code Division 10: Uniform Controlled Substances Act (cannabis provisions)accessed May 16, 2026
- California Department of Cannabis Controlaccessed May 16, 2026
- Compassionate Use Act of 1996 (Proposition 215): Health and Safety Code §11362.5accessed May 16, 2026
- Control, Regulate and Tax Adult Use of Marijuana Act (Proposition 64, 2016): Ballotpediaaccessed May 16, 2026
- NORML: California Laws & Penaltiesaccessed May 16, 2026
- NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 15, 2026
- FDA: Dronabinol (Marinol) prescribing informationaccessed May 15, 2026